Ambulatory blood pressure monitoring in children after renal transplantation

Transplantation Proceedings
Tomáš SeemanJan Janda

Abstract

Arterial hypertension is a common complication in children after renal transplantation and the control of hypertension is often difficult. This retrospective investigates the prevalence and rate of control of hypertension using ambulatory blood pressure monitoring (ABPM) in 45 children (mean age 14.1 +/- 4.3 years, mean time after renal transplantation 2.2 +/- 2.7 years), all on cyclosporine or tacrolimus, azathioprine or mycophenolate mofetil plus daily steroids. The overall prevalence of hypertension was 82%. None of the transplanted children had normal blood pressure without antihypertensive therapy (ie, spontaneous normotension). Twenty percent of children had untreated hypertension, 18% had controlled hypertension, and 62% had uncontrolled hypertension. Prevalence of the nondipping phenomenon was 53%. The mean number of antihypertensive drugs (without diuretic monotherapy) in treated patients was 1.9 drugs per patient. The prevalence of arterial hypertension in children after renal transplantation is high and the control of hypertension is often unsatisfactorily low.

References

Feb 1, 1997·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·N LingensK Schärer
Feb 1, 1997·Transplantation Proceedings·K BuddeH H Neumayer
Jun 11, 1999·Journal of the American Society of Nephrology : JASN·J M SorofR J Portman
Sep 12, 2001·Current Hypertension Reports·V SchwengerE Ritz
Oct 31, 2001·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·H MorganJ W Balfe
Mar 26, 2003·Pediatric Transplantation·Mark M Mitsnefes, Ronald J Portman

❮ Previous
Next ❯

Citations

Jan 7, 2014·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Bora GülhanNesrin Beşbaş
Jul 11, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·John W Graves, Mohammed Mahdi Althaf
Oct 24, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Tomás Seeman
Feb 26, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Alisa A Acosta, Karen L McNiece
Jun 23, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Michelle R DenburgMary B Leonard
Sep 27, 2012·Current Hypertension Reports·Tomáš Seeman
Mar 8, 2011·Indian Pediatrics·Rajiv Sinha, Janis Dionne
Feb 14, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Manish D SinhaUNKNOWN British Association for Paediatric Nephrology
Jul 22, 2006·Pediatric Transplantation·Kim R McGlothanDeborah P Jones
Jan 24, 2007·Pediatric Transplantation·Rene' G VanDe Voorde, Mark M Mitsnefes
Jan 25, 2011·Biochimica Et Biophysica Acta·Sara TerrynOlivier Devuyst
Aug 27, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Rafael T Krmar, Jorge R Ferraris
May 15, 2007·Current Opinion in Pediatrics·Karen L McNiece, Ronald J Portman
Feb 6, 2015·Journal of the American Society of Nephrology : JASN·Matthew R WeirSandra J Taler
Dec 23, 2011·Physiological Research·H M DvořákováJ Piťha
Jun 3, 2017·American Journal of Hypertension·Gilad HamdaniMark M Mitsnefes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2022 Meta ULC. All rights reserved